UVA Study Identifies Blood Biomarkers Linked to SIDS Risk

A new study from the University of Virginia School of Medicine has identified specific blood biomarkers associated with Sudden Infant Death Syndrome (SIDS), potentially paving the way for future risk assessment tests. The research, published in eBioMedicine, analyzed blood serum samples from 300 infants, including SIDS cases and controls, examining 828 different metabolites.

The study, led by Keith L. Keene and his team, identified 35 predictors of SIDS after adjusting for factors such as age, sex, race, and ethnicity. Among these biomarkers were ornithine, a substance involved in ammonia disposal, and a lipid metabolite crucial for brain and lung health. 

Chad Aldridge, first author on the paper, noted, "We found differences in specific fats, called sphingomyelins, which are critical for brain and lung development. Differences in these fats may disrupt these critical processes, placing some infants at risk for SIDS."

The research team emphasized that while these findings are promising, further investigation is needed to determine if these metabolites directly contribute to SIDS. Fern R. Hauck, a leading SIDS expert involved in the study, added, "The results of this study are very exciting—we are getting closer to explaining the pathways leading to a SIDS death."

According to the team, this study represents the largest effort to date in identifying blood biomarkers for SIDS. The researchers hope their work will lead to the development of simple blood tests to identify infants at higher risk for SIDS. However, they caution that more research is necessary before such tests become available.